Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hepion Pharmaceuticals Inc (NQ: HEPA )

2.130 +0.090 (+4.41%)
Streaming Delayed Price Updated: 3:59 PM EDT, Apr 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,542
Open 2.050
Bid (Size) 2.000 (1)
Ask (Size) 2.440 (1)
Prev. Close 2.040
Today's Range 2.000 - 2.210
52wk Range 1.490 - 16.00
Shares Outstanding 76,225,245
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
HEPA Stock Earnings: Hepion Pharmaceuticals Beats EPS for Q4 2023
HEPA stock results show that Hepion Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga

Performance

YTD
-32.38%
-32.38%
1 Month
-2.29%
-2.29%
3 Month
-16.80%
-16.80%
6 Month
-51.59%
-51.59%
1 Year
-85.87%
-85.87%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Is SeqLL (SQL) Stock Up 43% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Over $18M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Microvast Holdings Shares Are Trading Lower By Around 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Tesla, Zoom, Hepion, Pfizer, ZIM: Why These 5 Stocks Are Drawing Investor Attention Today
Via Benzinga
Hepion Pharmaceuticals (NASDAQ: HEPA) Reports Promising Phase 2 Trial Results for NASH Treatment
Via Spotlight Growth
Topics Death
Exposures Death
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Wall Street Mixed As Default Showdown Drags On
Via Talk Markets
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
US Stocks Mixed; Nordic American Tankers Posts Upbeat Results
Via Benzinga
Why is Mallinckrodt (MNK) Stock Down 27% Today?
Via InvestorPlace
Why Is Volcon (VLCN) Stock Down 37% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Hepion Pharmaceuticals Stock Is Soaring Monday
Via Benzinga
Why Is Hepion Pharmaceuticals (HEPA) Stock Up 68% Today?
Via InvestorPlace
Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.